More than 100 million people globally have had a stroke, but there are ways to reduce your risk and spot the signs of stroke ...
Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with bipolar disorders or ...
The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to each ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results